ARCUTIS BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.36 USD | -4.34% |
|
-4.78% | +220.74% |
Chart calendar Arcutis Biotherapeutics, Inc.
aca4bf9969af87.LZnjxDuSUwmBXTUv8QUvIyngLEHQWxrxd5ut6XkMn8s.FP6gqFH8GyTTbAFbvUZeeWXUeSqKNVSeEPyekBhvwJpC1pedUdZhS_s7DQ~edcaa1eb4aaa702cd8ef39c3897e875b
Upcoming events on Arcutis Biotherapeutics, Inc.
Past events on Arcutis Biotherapeutics, Inc.
| 05/09/2024 11:20 pm | Morgan Stanley Healthcare Conference |
| 15/08/2024 02:00 am | Q2 2024 Earnings Call |
| 15/08/2024 01:30 am | Q2 2024 Earnings Release |
| 29/07/2024 06:00 pm | Investor Meeting - Key Opinion Leader |
| 14/06/2024 09:00 pm | Annual General Meeting |
| 12/06/2024 10:50 pm | Goldman Sachs Global Healthcare Conference |
| 11/06/2024 12:00 am | Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Abstract Number: 634 |
| 09/06/2024 04:30 am | Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Poster Number: 639 |
| 09/06/2024 04:30 am | Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Poster Number: 641 |
| 09/06/2024 04:30 am | Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Poster Number: 640 |
| 15/05/2024 02:00 am | Q1 2024 Earnings Call |
| 15/05/2024 01:30 am | Q1 2024 Earnings Release |
| 11/04/2024 11:45 pm | Needham Healthcare Conference |
| 11/03/2024 03:00 am | American Academy of Dermatology Meeting |
| 10/03/2024 04:55 am | American Academy of Dermatology Meeting |
| 05/03/2024 12:40 am | TD Cowen Health Care Conference |
| 27/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 27/02/2024 04:20 pm | Q4 2023 Earnings Release |
| 07/02/2024 08:30 pm | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 23/01/2024 03:00 am | ZORYVE® FDA Approval Call |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 3,69 2,88 27.9% | 59,6 57,5 3.73% | 163 | 247 | 393 |
|
EBITDA Million USD | Released Forecast Spread | -206 -205 -0.34% | -301 -309 2.74% | -240 -249 3.6% | -169 | -145 | -56,4 |
|
EBIT Million USD | Released Forecast Spread | -207 -211 1.92% | -302 -315 4.14% | -241 -249 3.01% | -172 | -121 | -5,27 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -206 -215 4.23% | -311 -327 4.73% | -259 -265 2.27% | -186 | -133 | 1,10 |
|
Net income Million USD | Released Forecast Spread | -206 -215 4.23% | -311 -327 4.73% | -262 -267 1.93% | -186 | -133 | 1,10 |
|
EPS USD | Released Forecast Spread | -4,18 -4,36 4.18% | -5,66 -5,96 4.98% | -3,78 -3,94 4.12% | -1,50 | -1,09 | 0,00 |
| Announcement Date | 22/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,73 0,66 9.85% | 2,96 2,05 44.74% | 2,78 3,11 -10.7% | 5,19 4,62 12.42% | 38,1 30,8 23.65% | 13,5 11,4 18.77% | 49,6 15,1 227.4% | 30,9 29,1 6.11% | 37,0 | 46,5 | 55,0 | 63,0 | 71,0 | 71,0 |
|
EBITDA Million USD | Released Forecast Spread | -105 -101 -3.66% | -68,3 -77,3 11.69% | -76,1 -73,0 -4.23% | -66,6 | -36,7 -46,0 20.21% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -105 -102 -3.05% | -68,4 -82,4 17% | -76,3 -72,8 -4.75% | -66,8 -72,9 8.47% | -36,9 -49,3 25.16% | -61,2 -67,3 9.16% | -31,6 -62,5 49.38% | -50,1 -53,0 5.44% | -47,9 | -42,0 | -32,9 | -29,1 | -25,2 | -32,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -108 -111 3.34% | -72,0 -88,1 18.29% | -80,1 -76,6 -4.62% | -71,0 -76,4 7.08% | -41,7 -55,6 24.88% | -66,3 -72,3 8.4% | -35,1 -67,3 47.91% | -52,3 -56,9 7.97% | -51,3 | -45,5 | -37,9 | -34,1 | -30,2 | -37,8 |
|
Net income Million USD | Released Forecast Spread | -108 -104 -3.47% | -72,0 -88,1 18.29% | -80,1 -76,6 -4.62% | -71,0 -76,4 7.08% | -44,8 -55,6 19.44% | -66,3 -71,3 7.04% | -35,4 -67,3 47.43% | -52,3 -56,9 7.97% | -51,3 | -45,4 | -37,9 | -34,1 | -30,2 | -37,8 |
|
EPS USD | Released Forecast Spread | -1,89 -1,88 -0.35% | -1,18 -1,45 18.43% | -1,31 -1,25 -4.52% | -1,16 -1,24 6.45% | -0,73 -0,88 16.57% | -0,72 -0,79 8.57% | -0,32 -0,73 56.16% | -0,42 -0,51 18.05% | -0,42 | -0,37 | -0,30 | -0,25 | -0,25 | -0,35 |
| Announcement Date | 08/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 03/11/23 | 27/02/24 | 14/05/24 | 14/08/24 | - | - | - | - | - | - |
More events
Past sector events for Arcutis Biotherapeutics, Inc.
| 05/09/2024 01:50 pm | PHARMAESSENTIA CORPORATION: August 2024 Sales and Revenue Release |
| 04/09/2024 01:31 am | ASCENDIS PHARMA A/S: Q2 2024 Earnings Release |
| 03/09/2024 04:35 pm | GH RESEARCH PLC: Q2 2024 Earnings Release |
| 28/08/2024 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 28/08/2024 | AKESO, INC.: Q2 2024 Earnings Release |
| 27/08/2024 06:40 pm | KEYMED BIOSCIENCES INC.: Q2 2024 Earnings Release |
| 27/08/2024 | BEIGENE, LTD.: Q2 2024 Earnings Release |
| 26/08/2024 | HITGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/08/2024 06:20 am | CLARITY PHARMACEUTICALS LTD: Q4 2024 Earnings Release |
| 23/08/2024 | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARQT Stock
- Calendar Arcutis Biotherapeutics, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition